Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Expression of ProEx C in primary and metastatic urothelial carcinoma.

Liu L, Cohen C, Siddiqui MT.

Diagn Cytopathol. 2015 Mar;43(3):181-7. doi: 10.1002/dc.23193. Epub 2014 Jun 28.

PMID:
24975746
2.

Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.

Moatamed NA, Vergara-Lluri ME, Lu D, Apple SK, Kerkoutian S, Rao JY.

Hum Pathol. 2013 Nov;44(11):2509-17. doi: 10.1016/j.humpath.2013.06.011. Epub 2013 Sep 9.

PMID:
24029711
3.

ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.

Moatamed NA, Rao JY, Alexanian S, Cobarrubias M, Levin M, Lu D, Apple SK.

Cancer Cytopathol. 2013 Jun;121(6):320-8. doi: 10.1002/cncy.21264. Epub 2013 Jan 30.

4.

Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.

Yan S, Coffing BN, Li Z, Xie H, Brennick JB, Beg HA, Froehlich HM, Wells WA.

Anticancer Res. 2016 Jun;36(6):2871-80.

PMID:
27272799
5.

ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.

Botti G, Malzone MG, La Mantia E, Montanari M, Vanacore D, Rossetti S, Quagliariello V, Cavaliere C, Di Franco R, Castaldo L, Ametrano G, Cappuccio F, Romano FJ, Piscitelli R, Pepe MF, D'Aniello C, Facchini G.

Int J Med Sci. 2017 Apr 21;14(6):554-559. doi: 10.7150/ijms.17890. eCollection 2017. Review.

6.

GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases.

Siddiqui MT, Seydafkan S, Cohen C.

Diagn Cytopathol. 2014 Sep;42(9):809-15. doi: 10.1002/dc.23131. Epub 2014 Feb 28.

PMID:
24578300
7.

Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A.

Chen H, Gonzalez JL, Brennick JB, Liu M, Yan S.

Am J Surg Pathol. 2010 Sep;34(9):1250-7. doi: 10.1097/PAS.0b013e3181ecf829.

PMID:
20697251
8.

Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.

Vergara-Lluri ME, Hu E, Rao JY, Levin M, Apple SK, Moatamed NA.

Arch Pathol Lab Med. 2014 Sep;138(9):1215-22. doi: 10.5858/arpa.2013-0433-OA.

PMID:
25171704
9.

Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.

Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR.

Cancer. 2008 Dec 25;114(6):474-80. doi: 10.1002/cncr.23951.

10.
11.

BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.

Badr RE, Walts AE, Chung F, Bose S.

Am J Surg Pathol. 2008 Jun;32(6):899-906. doi: 10.1097/PAS.0b013e31815bbb69.

PMID:
18425044
12.

Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.

Dixon EP, King LM, Nelson R, Simkins SG, Knapp SL, Brough GH, Lenz KL, Henderson DT, Whitehead CM, Hessling J, Brown CA, Malinowski DP.

J Immunol Methods. 2017 Mar;442:35-41. doi: 10.1016/j.jim.2017.01.002. Epub 2017 Jan 16.

PMID:
28093271
13.

Fascin as an identifier of metastatic urothelial carcinoma: A retrospective study of fine-needle aspiration cell blocks and histologic tissue microarrays.

Vogt AP, Cohen C, Siddiqui MT.

Diagn Cytopathol. 2012 Oct;40(10):882-6. doi: 10.1002/dc.21668. Epub 2011 Mar 22.

PMID:
21433004
14.

Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.

Shi J, Liu H, Wilkerson M, Huang Y, Meschter S, Dupree W, Schuerch C, Lin F.

Hum Pathol. 2007 Sep;38(9):1335-44. Epub 2007 May 18.

PMID:
17512033
16.

ProEx C stain analysis in recurrent respiratory papillomatosis.

Bhandarkar ND, Sims HS, David O.

Ann Otol Rhinol Laryngol. 2010 Feb;119(2):99-104.

PMID:
20336920
17.

Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.

Boucher J, Anku-Bertholet C, Temmar R, Pelmus M.

Hum Pathol. 2009 Jun;40(6):904-5; author reply 905-6. doi: 10.1016/j.humpath.2009.02.004. No abstract available.

PMID:
19442790
18.

Utility of uroplakin II expression as a marker of urothelial carcinoma.

Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ.

Hum Pathol. 2015 Jan;46(1):58-64. doi: 10.1016/j.humpath.2014.09.007. Epub 2014 Oct 2.

PMID:
25449628
19.

Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.

Oberg TN, Kipp BR, Vrana JA, Bartholet MK, Fales CJ, Garcia R, McDonald AN, Rosas BL, Henry MR, Clayton AC.

Diagn Cytopathol. 2010 Aug;38(8):564-72. doi: 10.1002/dc.21251.

PMID:
19937941
20.

Supplemental Content

Support Center